Company Raises Full Year 2025 Financial Guidance CHARLESTON, S.C., July 30, 2025 /PRNewswire/ -- Blackbaud (NASDAQ: BLKB), the leading provider of software for ...

Media Release The pivotal TACTI-004 Phase III trial in first line non-small cell lung cancer (1L NSCLC) continues to build momentum and is recruiting patients at a growing number of activated clinical ...